Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceuticals ranked by total assets, at PLN 836.5B, ahead of Johnson & Johnson (PLN 800.5B) and Sanofi (PLN 565.4B). Figures as of 18 Nov 2026, 13:57 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerPLN 836.5B
- Median
- PLN 14.2B
- Combined market value
- PLN 20.73T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | PLN 836.5B | PLN 652.1B | PLN 114.41 | 1.35% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | PLN 800.5B | PLN 2.7T | PLN 1,119.96 | 1.36% down | 38% up | ||
| 3 | SanofiSNY · Health Care | PLN 565.4B | PLN 458.6B | PLN 191.00 | 1.78% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | PLN 550B | PLN 1.42T | PLN 576.13 | 0.75% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | PLN 538.3B | PLN 2.08T | PLN 1,176.70 | 0.59% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | PLN 458.4B | PLN 1.14T | PLN 732.45 | 0.95% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | PLN 452B | PLN 5.07T | PLN 5,688.39 | 1.13% down | 35% up | ||
| 8 | NovartisNVS · Health Care | PLN 445.8B | PLN 1.21T | PLN 639.46 | 0.67% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | PLN 390.4B | PLN 277.8B | PLN 86.96 | 0.23% up | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | PLN 361.8B | PLN 503.9B | PLN 246.53 | 2.51% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | PLN 348.5B | PLN 728.8B | PLN 420.78 | 2.55% down | 17% down | ||
| 12 | GSKGSK · Health Care | PLN 326B | PLN 396.6B | PLN 197.87 | 2.32% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | PLN 323.8B | PLN 720.8B | PLN 163.55 | 2.16% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 163.7B | PLN 199.8B | PLN 171.27 | 0.12% up | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | PLN 163B | PLN 398.1B | PLN 3,848.76 | 0.56% up | 36% up | ||
| 16 | ViatrisVTRS · Health Care | PLN 149.5B | PLN 94.2B | PLN 82.18 | 1.40% down | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | PLN 103B | PLN 544.3B | PLN 2,146.68 | 0.67% down | 27% up | ||
| 18 | GrifolsGRFS · Health Care | PLN 87.9B | PLN 23.6B | PLN 34.68 | 1.15% down | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | PLN 78.8B | PLN 158.7B | PLN 275.99 | 0.23% up | 78% up | ||
| 20 | ZoetisZTS · Health Care | PLN 62.2B | PLN 136.3B | PLN 335.46 | 1.08% down | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | PLN 53.7B | PLN 51.9B | PLN 103.88 | 2.12% down | 20% up | ||
| 22 | GenmabGMAB · Health Care | PLN 51.7B | PLN 128.7B | PLN 208.80 | 0.76% up | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 46.9B | PLN 62.1B | PLN 967.29 | 0.39% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | PLN 32.9B | PLN 189.7B | PLN 1,660.69 | 0.48% up | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | PLN 31.7B | PLN 100B | PLN 2,347.21 | 0.64% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | PLN 30.5B | PLN 45.5B | PLN 235.12 | 0.90% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 24.8B | PLN 49.5B | PLN 59.43 | 0.61% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | PLN 22.9B | PLN 112.7B | PLN 155.56 | 0.26% up | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | PLN 20B | PLN 84.2B | PLN 628.90 | 2.02% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | PLN 14.8B | PLN 29.6B | PLN 84.87 | 0.52% down | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | PLN 14.2B | PLN 18B | PLN 108.34 | 3.75% down | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | PLN 11.6B | PLN 20.3B | PLN 242.56 | 1.00% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | PLN 10B | PLN 30.7B | PLN 182.64 | 2.32% down | 58% up | ||
| 34 | InsmedINSM · Health Care | PLN 9.1B | PLN 107.4B | PLN 489.69 | 0.83% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | PLN 7B | PLN 12.6B | PLN 64.74 | 0.75% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | PLN 6.3B | PLN 23.6B | PLN 1,180.68 | 2.62% down | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | PLN 5.8B | PLN 71.5B | PLN 1,089.78 | 0.20% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | PLN 5.7B | PLN 28.9B | PLN 207.56 | 2.86% down | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 5.6B | PLN 24.4B | PLN 172.76 | 2.76% down | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 5.1B | PLN 39.4B | PLN 1,695.77 | 0.46% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | PLN 4.3B | PLN 38.1B | PLN 252.00 | 0.08% down | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | PLN 3.8B | PLN 34.3B | PLN 1,225.88 | 1.68% down | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | PLN 3.8B | PLN 19.5B | PLN 111.92 | 1.49% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | PLN 3.8B | PLN 60.1B | PLN 308.62 | 0.72% down | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | PLN 3.4B | PLN 24.1B | PLN 369.50 | 0.40% up | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | PLN 3.4B | PLN 30.8B | PLN 281.58 | 1.23% up | 8% down | ||
| 47 | Belite BioBLTE · Health Care | PLN 3.1B | PLN 25.7B | PLN 633.80 | 2.98% down | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | PLN 3.1B | PLN 35.8B | PLN 376.98 | 5.60% down | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 3.1B | PLN 30B | PLN 382.20 | 0.93% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | PLN 3B | PLN 34.3B | PLN 42.88 | 9.73% down | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | PLN 2.8B | PLN 28.7B | PLN 546.32 | 0.77% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | PLN 2.7B | PLN 32.7B | PLN 500.99 | 0.13% down | 46% up | ||
| 53 | ABIVAXABVX · Health Care | PLN 2.6B | PLN 28.9B | PLN 329.92 | 1.81% down | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | PLN 2.4B | PLN 19.7B | PLN 205.35 | 2.82% up | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | PLN 2.2B | PLN 18.5B | PLN 168.94 | 3.75% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | PLN 2.1B | PLN 19.7B | PLN 349.53 | 2.87% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | PLN 2B | PLN 26.3B | PLN 387.06 | 2.94% down | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 1.9B | PLN 32.5B | PLN 468.60 | 8.49% up | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | PLN 1.8B | PLN 16.2B | PLN 118.06 | 2.59% down | 169% up | ||
| 60 | ErascaERAS · Health Care | PLN 1.6B | PLN 19.6B | PLN 55.82 | 8.07% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | PLN 613.3M | PLN 21.3B | PLN 504.88 | 1.88% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0185 PLN).
Questions and answers
Which pharmaceuticals rank first by total assets?
Pfizer (PLN 836.5B), Johnson & Johnson (PLN 800.5B) and Sanofi (PLN 565.4B) are the top three of the 61 pharmaceuticals ranked by total assets as of 18 Nov 2026, 13:57 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of PLN 20.73T as of 18 Nov 2026, 13:57 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.